ID   PLEC_RAT                Reviewed;        4687 AA.
AC   P30427; O08879; O08880; O08881;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   02-OCT-2024, entry version 183.
DE   RecName: Full=Plectin;
DE            Short=PCN;
DE            Short=PLTN;
DE   AltName: Full=Plectin-1;
GN   Name=Plec; Synonyms=Plec1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Glial tumor;
RX   PubMed=2050743; DOI=10.1083/jcb.114.1.83;
RA   Wiche G., Becker B., Luber K., Weitzer G., Castanon M.J., Hauptmann R.,
RA   Stratowa C., Stewart M.;
RT   "Cloning and sequencing of rat plectin indicates a 466-kD polypeptide chain
RT   with a three-domain structure based on a central alpha-helical coiled
RT   coil.";
RL   J. Cell Biol. 114:83-99(1991).
RN   [2]
RP   SEQUENCE REVISION.
RC   TISSUE=Glial tumor;
RX   PubMed=8633055; DOI=10.1073/pnas.93.9.4278;
RA   Liu C.-G., Maercker C., Castanon M.J., Hauptmann R., Wiche G.;
RT   "Human plectin: organization of the gene, sequence analysis, and chromosome
RT   localization (8q24).";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:4278-4283(1996).
RN   [3]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Glial tumor;
RX   PubMed=9177781; DOI=10.1006/geno.1997.4724;
RA   Elliott C.E., Becker B., Oehler S., Castanon M.J., Hauptmann R., Wiche G.;
RT   "Plectin transcript diversity: identification and tissue distribution of
RT   variants with distinct first coding exons and rodless isoforms.";
RL   Genomics 42:115-125(1997).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-4033; SER-4387; SER-4388;
RP   SER-4389; SER-4392 AND SER-4394, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [5]
RP   INTERACTION WITH ANK3.
RX   PubMed=21223964; DOI=10.1016/j.yexcr.2011.01.002;
RA   Maiweilidan Y., Klauza I., Kordeli E.;
RT   "Novel interactions of ankyrins-G at the costameres: the muscle-specific
RT   Obscurin/Titin-Binding-related Domain (OTBD) binds plectin and filamin C.";
RL   Exp. Cell Res. 317:724-736(2011).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-723; SER-1050; SER-1438;
RP   SER-2777; SER-3583; THR-4033; SER-4389; SER-4392; SER-4409; SER-4616 AND
RP   SER-4629, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Interlinks intermediate filaments with microtubules and
CC       microfilaments and anchors intermediate filaments to desmosomes or
CC       hemidesmosomes. May be involved not only in the cross-linking and
CC       stabilization of cytoskeletal intermediate filaments network, but also
CC       in the regulation of their dynamics.
CC   -!- SUBUNIT: Homodimer or homotetramer (By similarity). Interacts (via
CC       actin-binding domain) with SYNE3. Interacts (via calponin-homology (CH)
CC       1 domain) with VIM (via rod region). Interacts (via N-terminus) with
CC       DST isoform 2 (via N-terminus). Interacts with FER. Interacts with
CC       TOR1A (By similarity). Interacts with ANK3 (PubMed:21223964).
CC       Identified in complexes that contain VIM, EZR, AHNAK, BFSP1, BFSP2,
CC       ANK2, PLEC, PRX and spectrin (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q9QXS1, ECO:0000269|PubMed:21223964}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q15149}. Cell junction, hemidesmosome
CC       {ECO:0000250|UniProtKB:Q15149}. Cell projection, podosome
CC       {ECO:0000250|UniProtKB:Q9QXS1}. Note=Localized to the cortex of myotube
CC       podosomes. {ECO:0000250|UniProtKB:Q9QXS1}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P30427-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P30427-2; Sequence=VSP_005050;
CC       Name=3;
CC         IsoId=P30427-3; Sequence=VSP_005051;
CC       Name=4;
CC         IsoId=P30427-4; Sequence=VSP_005052;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest expression in
CC       skeletal muscle and lowest in thymus. {ECO:0000269|PubMed:9177781}.
CC   -!- DOMAIN: The N-terminus interacts with actin, the C-terminus with
CC       vimentin, desmin, GFAP, cytokeratins, lamin B; whereas both the N- and
CC       the C-terminus can bind integrin beta-4.
CC   -!- PTM: Phosphorylated by CDK1; regulates dissociation from intermediate
CC       filaments during mitosis. Isoform 2 is phosphorylated on Ser-21 and
CC       Tyr-26 (By similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Incomplete sequence. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the plakin or cytolinker family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X59601; CAA42169.1; -; mRNA.
DR   EMBL; U96274; AAC53209.1; -; mRNA.
DR   EMBL; U96275; AAC53210.1; -; mRNA.
DR   EMBL; U96276; AAC53211.1; -; mRNA.
DR   PIR; A39638; A39638.
DR   SMR; P30427; -.
DR   IntAct; P30427; 4.
DR   MINT; P30427; -.
DR   STRING; 10116.ENSRNOP00000073548; -.
DR   CarbonylDB; P30427; -.
DR   iPTMnet; P30427; -.
DR   PhosphoSitePlus; P30427; -.
DR   jPOST; P30427; -.
DR   PaxDb; 10116-ENSRNOP00000040018; -.
DR   UCSC; RGD:621649; rat. [P30427-1]
DR   AGR; RGD:621649; -.
DR   RGD; 621649; Plec.
DR   eggNOG; KOG0516; Eukaryota.
DR   InParanoid; P30427; -.
DR   PhylomeDB; P30427; -.
DR   Reactome; R-RNO-264870; Caspase-mediated cleavage of cytoskeletal proteins.
DR   Reactome; R-RNO-446107; Type I hemidesmosome assembly.
DR   PRO; PR:P30427; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:RGD.
DR   GO; GO:0005903; C:brush border; ISO:RGD.
DR   GO; GO:0071944; C:cell periphery; ISO:RGD.
DR   GO; GO:0043292; C:contractile muscle fiber; ISO:RGD.
DR   GO; GO:0043034; C:costamere; TAS:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0005925; C:focal adhesion; IBA:GO_Central.
DR   GO; GO:0030056; C:hemidesmosome; ISS:UniProtKB.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISO:RGD.
DR   GO; GO:0043209; C:myelin sheath; ISO:RGD.
DR   GO; GO:0030016; C:myofibril; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0002102; C:podosome; ISS:UniProtKB.
DR   GO; GO:0042383; C:sarcolemma; IDA:BHF-UCL.
DR   GO; GO:0016528; C:sarcoplasm; IDA:BHF-UCL.
DR   GO; GO:0030018; C:Z disc; ISO:RGD.
DR   GO; GO:0003779; F:actin binding; ISO:RGD.
DR   GO; GO:0051015; F:actin filament binding; ISO:RGD.
DR   GO; GO:0030506; F:ankyrin binding; IPI:BHF-UCL.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IDA:RGD.
DR   GO; GO:0002162; F:dystroglycan binding; ISO:RGD.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IMP:RGD.
DR   GO; GO:0008307; F:structural constituent of muscle; IBA:GO_Central.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0007015; P:actin filament organization; ISO:RGD.
DR   GO; GO:2000689; P:actomyosin contractile ring assembly actin filament organization; ISO:RGD.
DR   GO; GO:0034332; P:adherens junction organization; ISO:RGD.
DR   GO; GO:0055013; P:cardiac muscle cell development; ISO:RGD.
DR   GO; GO:0000902; P:cell morphogenesis; ISO:RGD.
DR   GO; GO:0048870; P:cell motility; ISO:RGD.
DR   GO; GO:0071498; P:cellular response to fluid shear stress; ISO:RGD.
DR   GO; GO:0071464; P:cellular response to hydrostatic pressure; ISO:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISO:RGD.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEP:RGD.
DR   GO; GO:0061436; P:establishment of skin barrier; ISO:RGD.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0010761; P:fibroblast migration; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0031581; P:hemidesmosome assembly; ISS:UniProtKB.
DR   GO; GO:0045104; P:intermediate filament cytoskeleton organization; ISO:RGD.
DR   GO; GO:0045109; P:intermediate filament organization; ISO:RGD.
DR   GO; GO:0003334; P:keratinocyte development; ISO:RGD.
DR   GO; GO:0030216; P:keratinocyte differentiation; ISO:RGD.
DR   GO; GO:0002522; P:leukocyte migration involved in immune response; ISO:RGD.
DR   GO; GO:0007005; P:mitochondrion organization; ISO:RGD.
DR   GO; GO:0035264; P:multicellular organism growth; ISO:RGD.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; ISO:RGD.
DR   GO; GO:0045445; P:myoblast differentiation; ISO:RGD.
DR   GO; GO:0006997; P:nucleus organization; ISO:RGD.
DR   GO; GO:0032287; P:peripheral nervous system myelin maintenance; ISO:RGD.
DR   GO; GO:0008104; P:protein localization; ISO:RGD.
DR   GO; GO:0043933; P:protein-containing complex organization; ISO:RGD.
DR   GO; GO:0043114; P:regulation of vascular permeability; ISO:RGD.
DR   GO; GO:0022904; P:respiratory electron transport chain; ISO:RGD.
DR   GO; GO:0032094; P:response to food; ISO:RGD.
DR   GO; GO:0007584; P:response to nutrient; IDA:RGD.
DR   GO; GO:0045214; P:sarcomere organization; ISO:RGD.
DR   GO; GO:0048741; P:skeletal muscle fiber development; ISO:RGD.
DR   GO; GO:0007519; P:skeletal muscle tissue development; ISO:RGD.
DR   GO; GO:0014866; P:skeletal myofibril assembly; ISO:RGD.
DR   GO; GO:0043588; P:skin development; ISO:RGD.
DR   GO; GO:0010818; P:T cell chemotaxis; ISO:RGD.
DR   GO; GO:0120193; P:tight junction organization; ISO:RGD.
DR   GO; GO:0019226; P:transmission of nerve impulse; ISO:RGD.
DR   GO; GO:0042060; P:wound healing; IBA:GO_Central.
DR   CDD; cd21188; CH_PLEC-like_rpt1; 1.
DR   CDD; cd21238; CH_PLEC_rpt2; 1.
DR   CDD; cd00176; SPEC; 2.
DR   Gene3D; 1.20.58.1060; -; 1.
DR   Gene3D; 1.20.58.60; -; 5.
DR   Gene3D; 3.30.160.780; -; 1.
DR   Gene3D; 1.10.418.10; Calponin-like domain; 2.
DR   Gene3D; 3.90.1290.10; Plakin repeat; 6.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH_dom.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR041615; Desmoplakin_SH3.
DR   InterPro; IPR041573; Desmoplakin_Spectrin-like.
DR   InterPro; IPR049538; PCN-like_spectrin-like_rpt.
DR   InterPro; IPR043197; Plakin.
DR   InterPro; IPR035915; Plakin_repeat_sf.
DR   InterPro; IPR005326; Plectin_eS10_N.
DR   InterPro; IPR001101; Plectin_repeat.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR018159; Spectrin/alpha-actinin.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   PANTHER; PTHR23169; ENVOPLAKIN; 1.
DR   PANTHER; PTHR23169:SF20; PLECTIN; 1.
DR   Pfam; PF00307; CH; 2.
DR   Pfam; PF00681; Plectin; 19.
DR   Pfam; PF03501; S10_plectin; 1.
DR   Pfam; PF17902; SH3_10; 1.
DR   Pfam; PF18373; Spectrin_2; 1.
DR   Pfam; PF21019; Spectrin_3; 1.
DR   Pfam; PF21020; Spectrin_4; 1.
DR   Pfam; PF21097; SR_plectin_7; 1.
DR   SMART; SM00033; CH; 2.
DR   SMART; SM00250; PLEC; 34.
DR   SMART; SM00150; SPEC; 6.
DR   SUPFAM; SSF47576; Calponin-homology domain, CH-domain; 1.
DR   SUPFAM; SSF75399; Plakin repeat; 7.
DR   SUPFAM; SSF46966; Spectrin repeat; 5.
DR   PROSITE; PS00020; ACTININ_2; 1.
DR   PROSITE; PS50021; CH; 2.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; Alternative splicing; Cell junction;
KW   Cell projection; Coiled coil; Cytoplasm; Cytoskeleton; Methylation;
KW   Phosphoprotein; Reference proteome; Repeat; SH3 domain.
FT   CHAIN           1..4687
FT                   /note="Plectin"
FT                   /id="PRO_0000078137"
FT   DOMAIN          185..288
FT                   /note="Calponin-homology (CH) 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   DOMAIN          301..406
FT                   /note="Calponin-homology (CH) 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   REPEAT          648..722
FT                   /note="Spectrin 1"
FT   REPEAT          743..827
FT                   /note="Spectrin 2"
FT   REPEAT          840..933
FT                   /note="Spectrin 3"
FT   DOMAIN          944..1001
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REPEAT          1318..1418
FT                   /note="Spectrin 4"
FT   REPEAT          2791..2828
FT                   /note="Plectin 1"
FT   REPEAT          2829..2866
FT                   /note="Plectin 2"
FT   REPEAT          2867..2904
FT                   /note="Plectin 3"
FT   REPEAT          2905..2942
FT                   /note="Plectin 4"
FT   REPEAT          2943..2980
FT                   /note="Plectin 5"
FT   REPEAT          2984..3018
FT                   /note="Plectin 6"
FT   REPEAT          3119..3156
FT                   /note="Plectin 7"
FT   REPEAT          3157..3194
FT                   /note="Plectin 8"
FT   REPEAT          3195..3232
FT                   /note="Plectin 9"
FT   REPEAT          3233..3270
FT                   /note="Plectin 10"
FT   REPEAT          3271..3308
FT                   /note="Plectin 11"
FT   REPEAT          3311..3346
FT                   /note="Plectin 12"
FT   REPEAT          3488..3525
FT                   /note="Plectin 13"
FT   REPEAT          3526..3563
FT                   /note="Plectin 14"
FT   REPEAT          3564..3601
FT                   /note="Plectin 15"
FT   REPEAT          3602..3639
FT                   /note="Plectin 16"
FT   REPEAT          3643..3677
FT                   /note="Plectin 17"
FT   REPEAT          3823..3860
FT                   /note="Plectin 18"
FT   REPEAT          3861..3898
FT                   /note="Plectin 19"
FT   REPEAT          3899..3936
FT                   /note="Plectin 20"
FT   REPEAT          3937..3974
FT                   /note="Plectin 21"
FT   REPEAT          3978..4011
FT                   /note="Plectin 22"
FT   REPEAT          4066..4103
FT                   /note="Plectin 23"
FT   REPEAT          4104..4141
FT                   /note="Plectin 24"
FT   REPEAT          4142..4179
FT                   /note="Plectin 25"
FT   REPEAT          4180..4217
FT                   /note="Plectin 26"
FT   REPEAT          4221..4255
FT                   /note="Plectin 27"
FT   REPEAT          4268..4308
FT                   /note="Plectin 28"
FT   REPEAT          4411..4448
FT                   /note="Plectin 29"
FT   REPEAT          4449..4486
FT                   /note="Plectin 30"
FT   REPEAT          4487..4524
FT                   /note="Plectin 31"
FT   REPEAT          4525..4562
FT                   /note="Plectin 32"
FT   REPEAT          4563..4600
FT                   /note="Plectin 33"
FT   REGION          1..1473
FT                   /note="Globular 1"
FT   REGION          111..158
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          181..406
FT                   /note="Actin-binding"
FT   REGION          1474..2758
FT                   /note="Central fibrous rod domain"
FT   REGION          1623..1647
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1741..1764
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1796..1846
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2096..2139
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2164..2188
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2218..2307
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2671..2710
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2759..4687
FT                   /note="Globular 2"
FT   REGION          4253..4303
FT                   /note="Binding to intermediate filaments"
FT   REGION          4614..4687
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          4628..4643
FT                   /note="4 X 4 AA tandem repeats of G-S-R-X"
FT   COILED          1472..1692
FT                   /evidence="ECO:0000255"
FT   COILED          1724..2760
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        134..156
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1800..1838
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2218..2260
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2671..2686
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2687..2710
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        4614..4671
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         723
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         818
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXS1"
FT   MOD_RES         1050
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1438
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1724
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         1728
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXS1"
FT   MOD_RES         2634
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         2639
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXS1"
FT   MOD_RES         2777
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2784
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXS1"
FT   MOD_RES         2805
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         2889
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         3036
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXS1"
FT   MOD_RES         3056
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXS1"
FT   MOD_RES         3094
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         3365
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXS1"
FT   MOD_RES         3423
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         3583
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         3788
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         3793
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXS1"
FT   MOD_RES         4033
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         4057
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4385
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4387
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         4388
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         4389
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         4392
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         4393
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4394
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         4395
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4396
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4399
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4409
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         4414
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4542
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JI55"
FT   MOD_RES         4610
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4616
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         4618
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXS1"
FT   MOD_RES         4619
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4621
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4625
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4626
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXS1"
FT   MOD_RES         4629
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         4630
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXS1"
FT   MOD_RES         4643
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4645
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4678
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   VAR_SEQ         1..180
FT                   /note="MVAGMLMPLDQLRAIYEVLFREGVMVAKKDRRPRSLHPHVPGVTNLQVMRAM
FT                   TSLKARGLVRETFAWCHFYWYLTNEGIDHLRQYLHLPPEIVPASLQRVRRPVAMVMPAR
FT                   RRSPHVQTMQGPLGCPPKRGPLPAEDPAREERQVYRRKEREEGAPETPVVSATIVGTLA
FT                   RPGPEPTPAT -> MSQQRLRVPEPEGLGSKRTSSEDNLYLAVLRASEGKK (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005050"
FT   VAR_SEQ         1..180
FT                   /note="MVAGMLMPLDQLRAIYEVLFREGVMVAKKDRRPRSLHPHVPGVTNLQVMRAM
FT                   TSLKARGLVRETFAWCHFYWYLTNEGIDHLRQYLHLPPEIVPASLQRVRRPVAMVMPAR
FT                   RRSPHVQTMQGPLGCPPKRGPLPAEDPAREERQVYRRKEREEGAPETPVVSATIVGTLA
FT                   RPGPEPTPAT -> MEPSGSLFPSLVVVGHVVSLAAVWHWRKGHRQAQDEQ (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005051"
FT   VAR_SEQ         1..180
FT                   /note="MVAGMLMPLDQLRAIYEVLFREGVMVAKKDRRPRSLHPHVPGVTNLQVMRAM
FT                   TSLKARGLVRETFAWCHFYWYLTNEGIDHLRQYLHLPPEIVPASLQRVRRPVAMVMPAR
FT                   RRSPHVQTMQGPLGCPPKRGPLPAEDPAREERQVYRRKEREEGAPETPVVSATIVGTLA
FT                   RPGPEPTPAT -> DVSNGSSGSPSPGDTLPWNLGKTQRSRRSGGGSVGNGSVLDPAER
FT                   AVIRIA (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005052"
FT   MOD_RES         P30427-2:21
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P30427-2:26
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXS1"
SQ   SEQUENCE   4687 AA;  533540 MW;  9966CAF71B929751 CRC64;
     MVAGMLMPLD QLRAIYEVLF REGVMVAKKD RRPRSLHPHV PGVTNLQVMR AMTSLKARGL
     VRETFAWCHF YWYLTNEGID HLRQYLHLPP EIVPASLQRV RRPVAMVMPA RRRSPHVQTM
     QGPLGCPPKR GPLPAEDPAR EERQVYRRKE REEGAPETPV VSATIVGTLA RPGPEPTPAT
     DERDRVQKKT STKWVNKHLI KAQRHISDLY EDLRDGHNLI SLLEVLSGDS LPREKGRMRF
     HKLQNVQIAL DYLRHRQVKL VNIRNDDIAD GNPKLTLGLI WTIILHFKIS DIQVSGQSED
     MTAKEKLLLW SQRMVEGYQG LRCDNFTTSW RDGRLFNAII HRHKPMLIDM NKVYRQTNLE
     NLDQAFSVAE RDLGVTRLLD PEDVDVPQPD EKSIITYVSS LYDAMPRVPG AQDGVRANEL
     QLRWQEYREL VLLLLQWIRH HTAAFEERKF PSSFEEIEIL WCQFLKFKET ELPAKEADKN
     RSKGIYQSLE GAVQAGQLKI PPGYHPLDVE KEWGKLHVAI LEREKQLRSE FERLECLQRI
     VSKLQMEAGL CEEQLYQADS LLQSDIRLLA SGKAAQRAGE VERDLDKADG MIRLLFNDVQ
     TLKDGRHPQG EQMYRRVYRL HERLVAIRTE YNLRLKAGVG APVTQVTLQS TQRRPELEDS
     TLRYLHDLLA WVEENQRRID GAEWGVDLPS VEAQLGSHRG MHQSIEEFRA KIERARNDES
     QLSPATRGAY RDCLGRLDLQ YAKLLNSSKA RLRSLESLHG FVAAATKELM WLNEKEEEEV
     GFDWSDRNTN MAAKKESYSA LMRELEMKEK KIKEIQNTGD RLLREDHPAR PTVESFQAAL
     QTQWSWMLQL CCCIEAHLKE NTAYFQFFSD VREAEEQLQK LQETLRRKYS CDRSITVTRL
     EDLLQDAQDE KEQLNEYKGH LSGLAKRAKA IVQLKPRNPA HPVRGHVPLL AVCDYKQVEV
     TVHKGDQCQL VGPAQPFHWK VLSSSGSEAA VPSVCFLVPP PNQEAQEAVA RLEAQHQALV
     TLWHQLHVDM KSLLAWQSLN RDIQLIRSWS LVTFRTLKPE EQRQALRNLE LHYQAFLRDS
     QDAGGFGPED RLVAEREYGS CSRHYQQLLQ SLEQGEQEES RCQRCISELK DIRLQLEACE
     TRTVHRLRLP LDKDPARECA QRIAEQQKAQ AEVEGLGKGV ARLSAEAEKV LALPEPSPAA
     PTLRSELELT LGKLEQVRSL SAIYLEKLKT ISLVIRSTQG AEEVLKTHEE HLKEAQAVPA
     TLQELEVTKA SLKKLRAQAE AQQPVFNTLR DELRGAQEVG ERLQQRHGER DVEVERWRER
     VTQLLERWQA VLAQTDVRQR ELEQLGRQLR YYRESADPLS SWLQDAKSRQ EQIQAVPIAN
     SQAAREQLRQ EKALLEEIER HGEKVEECQK FAKQYINAIK DYELQLITYK AQLEPVASPA
     KKPKVQSGSE SVIQEYVDLR TRYSELTTLT SQYIKFISET LRRMEEEERL AEQQRAEERE
     RLAEVEAALE KQRQLAEAHA QAKAQAELEA RELQRRMQEE VTRREEAAVD AQQQKRSIQE
     ELQHLRQSSE AEIQAKAQQV EAAERSRMRI EEEIRVVRLQ LETTERQRGG AEDELQALRA
     RAEEAEAQKR QAQEEAERLR RQVQDESQRK RQAEAELALR VKAEAEAARE KQRALQALDE
     LKLQAEEAER WLCQAEAERA RQVQVALETA QRSAEVELQS KRPSFAEKTA QLERTLQEEH
     VTVTQLREEA ERRAQQQAEA ERAREEAERE LERWQLKANE ALRLRLQAEE VAQQKSLAQA
     DAEKQKEEAE REARRRGKAE EQAVRQRELA EQELEKQRQL TEGTAQQRLA AEQELIRLRA
     ETEQGEHQRQ LLEEELARLQ HEATAATQKR QELEAELAKV RAEMEVLLAS KARAEEESRS
     TSEKSKQRLE AEAGRFRELA EEAARLRALA EEARRHRELA EEDAARQRAE ADGVLTEKLA
     AISEATRLKT EAEIALKEKE AENERLRRLA EDEAFQRRRL EEQAAQHKAD IEERLAQLRK
     ASESELERQK GLVEDTLRQR RQVEEEIMAL KASFEKAAAG KAELELELGR IRSNAEDTMR
     SKELAEQEAA RQRQLAAEEE QRRREAEERV QRSLAAEEEA ARQRKVALEE VERLKAKVEE
     ARRLRERAEQ ESARQLQLAQ EAAQKRLQAE EKAHAFVVQQ REEELQQTLQ QEQNMLERLR
     SEAEAARRAA EEAEEAREQA EREAAQSRKQ VEEAERLKQS AEEQAQAQAQ AQAAAEKLRK
     EAEQEAARRA QAEQAALKQK QAADAEMEKH KKFAEQTLRQ KAQVEQELTT LRLQLEETDH
     QKSILDEELQ RLKAEVTEAA RQRSQVEEEL FSVRVQMEEL GKLKARIEAE NRALILRDKD
     NTQRFLEEEA EKMKQVAEEA ARLSVAAQEA ARLRQLAEED LAQQRALAEK MLKEKMQAVQ
     EATRLKAEAE LLQQQKELAQ EQARRLQADK EQMAQQLVEE TQGFQRTLEA ERQRQLEMSA
     EAERLKLRMA EMSRAQARAE EDAQRFRKQA EEIGEKLHRT ELATQEKVTL VQTLEIQRQQ
     SDQDAERLRE AIAELEREKE KLKQEAKLLQ LKSEEMQTVQ QEQILQETQA LQKSFLSEKD
     SLLQRERFIE QEKAKLEQLF QDEVAKAKQL QEEQQRQQQQ MEQEKQELVA SMEEARRRQR
     EAEEGVRRKQ EELQRLEQQR QQQEKLLAEE NQRLRERLQR LEEEHRAALA HSEEIATSQA
     AATKALPNGR DALDGPSMEA EPEYTFEGLR QKVPAQQLQE AGILSMEELQ RLTQGHTTVA
     ELTQREDVRH YLKGGSSIAG LLLKPTNEKL SVYTALQRQL LSPGTALILL EAQAASGFLL
     DPVRNRRLTV NEAVKEGVVG PELHHKLLSA ERAVTGYKDP YTGEQISLFQ AMKKDLIVRD
     HGIRLLEAQI ATGGIIDPVH SHRVPVDVAY QRGYFDEEMN RVLADPSDDT KGFFDPNTHE
     NLTYLQLLER CVEDPETGLR LLPLTDKAAK GGELVYTDTE ARDVFEKATV SAPFGKFQGK
     TVTIWEIINS EYFTAEQRRD LLRQFRTGRI TVEKIIKIVI TVVEEHERKG QLCFEGLRAL
     VPAAELLDSG VISHEVYQQL QRGERSVREV AEADEVRQAL RGTSVIAGVW LEEAGQKLSI
     YEALRRDLLQ PEVAVALLEA QAGTGHIIDP ATSARLTVDE AVRAGLVGPE MHEKLLSAEK
     AVTGYRDPYS GQSVSLFQAL KKGLIPREQG LRLLDAQLST GGIVDPSKSH RVPLDVAYAR
     GYLDKETNRA LTSPRDDARV YLDPSTREPV TYSQLQQRCR SDQLTGLSLL PLSEKAVRAR
     QEEVYSELQA RETLEKAKVE VPVGGFKGRA LTVWELISSE YFTEEQRQEL LRQFRTGKVT
     VEKVIKILIT IVEEVETQRQ ERLSFSGLRA PVPASELLAS KILSRTQFEQ LKDGKTSVKD
     LSEVGSVRTL LQGSGCLAGI YLEDSKEKVT IYEAMRRGLL RASTATLLLE AQAATGFLVD
     PVRNQRLYVH EAVKAGVVGP ELHEKLLSAE KAVTGYKDPY SGSTISLFQA MKKGLVLRDH
     AIRLLEAQIA TGGIIDPVHS HRLPVDVAYQ RGYFDEEMNR VLADPSDDTK GFFDPNTHEN
     LTYLQLLERC VEDPETGLRL LPLRGAEKTE VVETTQVYTE EETRRAFEET QIDIPGGGSH
     GGSSMSLWEV MQSDMIPEDQ RARLMADFQA GRVTKERMII IIIEIIEKTE IIRQQNLASY
     DYVRRRLTAE DLYEARIISL ETYNLFREGT KSLREVLEME SAWRYLYGTG SVAGVYLPGS
     RQTLTIYQAL KKGLLSAEVA RLLLEAQAAT GFLLDPVKGE RLTVDEAVRK GLVGPELHDR
     LLSAERAVTG YRDPYTEQPI SLFQAMKKEL IPAEEALRLL DAQLATGGIV DPRLGFHLPL
     EVAYQRGYLN KDTHDQLSEP SEVRSYVDPS TDERLSYTQL LKRCRRDDNS GQMLLPLSDA
     RKLTFRGLRK QITVEELVRS QVMDEATALQ LQEGLTSIEE VTKNLQKFLE GTSCIAGVFV
     DATKERLSVY QAMKKGIIRP GTAFELLEAQ AATGYVIDPI KGLKLTVEEA VRMGIVGPEF
     KDKLLSAERA VTGYKDPYSG KLISLFQAMK KGLILKDHGI RLLEAQIATG GIIDPEESHR
     LPVEVAYKRG LFDEEMNEIL TDPSDDTKGF FDPNTEENLT YLQLMERCIT DPQTGLCLLP
     LKEKKRERKT SSKSSVRKRR VVIVDPETGK EMSVYEAYRK GLIDHQTYLE LSEQECEWEE
     ITISSSDGVV KSMIIDRRSG RQYDIGDAIT KNLIDRSALD QYRAGTLSIT EFADMLSGNA
     GGFRSRSSSV GSSSSYPISS AVPRTQLASW SDPTEETGPV AGILDTETLE KVSITEAMHR
     NLVDNITGQR LLEAQACTGG IIDPSTGERF PVTEAVNKGL VDKIMVDRIN LAQKAFCGFE
     DPRTKTKMSA AQALKKGWLY YEAGQRFLEV QYLTGGLIEP DTPGRVSLDE ALQRGTVDAR
     TAQKLRDVSA YSKYLTCPKT KLKISYKDAL DRSMVEEGTG LRLLEAAAQS SKGYYSPYSV
     SGSGSTAGSR TGSRTGSRAG SRRGSFDATG SGFSMTFSSS SYSSSGYGRR YASGPSASLG
     GPESAVA
//
